ArticleNPJ breast cancer2023
Clonal heterogeneity in ER+ breast cancer reveals the proteasome and PKC as potential therapeutic targets.
Lukas Beumers et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it